Quantcast

Latest Chronic obstructive pulmonary disease Stories

2014-09-11 04:21:18

OXFORD, England, September 11, 2014 /PRNewswire/ -- Successful Completion of Biomedical Catalyst Programme Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it has confirmed the potential of its Multi-component Particle(TM) (MCP(TM)) Technology for creating novel inhaled, dual and triple fixed dose combination (FDC) therapies for respiratory diseases. The Company...

2014-09-10 12:24:27

RIDGEFIELD, Conn., Sept. 10, 2014 /PRNewswire/ -- In support of Pulmonary Fibrosis Awareness Month, Boehringer Ingelheim Pharmaceuticals, Inc., announces the airing of Every Breath Counts: Idiopathic Pulmonary Fibrosis -- a documentary supported by the company and created in collaboration with the Pulmonary Fibrosis Foundation and the Coalition for Pulmonary Fibrosis in an effort to increase awareness and understanding of idiopathic pulmonary fibrosis (IPF) among the general public....

2014-09-09 12:28:55

Breathe NIOV System Also Wins European Respiratory Society POINT Award IRVINE, Calif., Sept. 9, 2014 /PRNewswire/ -- Breathe Technologies, a developer and manufacturer of innovative medical technologies for patients with respiratory insufficiency diseases and neuromuscular diseases, announced today that it received CE Certification for its Non-Invasive Open Ventilation (NIOV) System, enabling the company to market and sell the device in the European Union. In addition, the NIOV...

2014-09-09 08:31:47

LONDON, ON, Sept. 9, 2014 /PRNewswire/ - New study results presented today at the European Respiratory Society (ERS) Conference in Munich Germany provide further evidence that the Aerobika* OPEP device developed by Trudell Medical International (TMI) provides an important treatment for the 250 million patients suffering from COPD globally. Many of these patients suffer from excessive mucus resulting in breathlessness, the inability to do everyday activities, and decreased quality of...

2014-09-08 16:24:59

WWII Veteran Bob Scott to Tour Washington, D.C. Memorials Using the Breathe NIOV System IRVINE, Calif., Sept. 8, 2014 /PRNewswire/ -- Breathe Technologies, a developer and manufacturer of innovative medical technologies for patients with respiratory insufficiency diseases and neuromuscular diseases, will sponsor World War II Veteran and Colton, Calif. resident Bob Scott on a September trip to Washington, D.C., as part of the Honor Flight Network. The Breathe Non-Invasive Open...

2014-09-08 12:30:18

Additionally, data from the WISDOM trial on stepwise withdrawal of ICS in COPD was also presented at ERS and simultaneously published in the New England Journal of Medicine RIDGEFIELD, Conn., Sept. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented the first data from the pivotal Phase III TONADO(TM) 1&2 studies (NCT01431274/NCT01431287) for the fixed-dose combination (FDC) of tiotropium plus olodaterol delivered via the Respimat(®) inhaler in patients with moderate to...

2014-09-08 08:29:55

-- LANTERN study met primary endpoint demonstrating non-inferiority of Ultibro® Breezhaler® 110/50 mcg vs Advair* Diskus* (SFC) 50/500 mcg followed by statistically significant superiority in post dose trough FEV1 after 26 weeks of treatment in patients with moderate-to-severe COPD1 -- In addition, LANTERN study met an endpoint demonstrating that Ultibro®Breezhaler ® reduced...

2014-09-04 23:03:46

MedicationDiscountCard.com offers Veramyst discount cards, along with discount cards for other similar medications. These discount cards can save patients 10-75% on prescription drugs that treat or help manage COPD. Margate City, NJ (PRWEB) September 04, 2014 Recent reports from the Centers for Disease Control indicate that nearly 7% of the US population is currently dealing with chronic obstructive pulmonary disease, or COPD (cdc.gov/Features/copdadults/). It may also be called COLD...

2014-09-04 08:31:03

Company to scale FDA-cleared digital therapeutic to tackle $100 billion cost of treating asthma and chronic obstructive pulmonary disease (COPD) MADISON, Wisc. and WAYNE, Penn., Sept. 4, 2014 /PRNewswire/ -- Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced that it raised $14.5 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor The Social+Capital Partnership....

2014-09-04 08:30:17

WASHINGTON, Sept. 4, 2014 /PRNewswire-USNewswire/ -- Smoking cigarettes or drinking too much alcohol can cause addiction and other serious health issues. The risk of diseases associated with tobacco and alcohol increase for those who drink and smoke. According to the National Institutes of Health (NIH), about 443,000 people in the United States die of illnesses caused by tobacco each year. Meanwhile, about 88,000 die from alcohol-related illnesses. Diseases caused by smoking tobacco Smoking...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'